{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Yeonsu",
      "state": "N/A",
      "country": "Korea (the Republic of)",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97710",
      "recalling_firm": "Samsung Bioepis Co., Ltd.",
      "address_1": "76 Songdogyoyuk-Ro",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed only to one warehouse in NJ. with no further distribution",
      "recall_number": "D-0099-2026",
      "product_description": "HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for: Organon LLC, a subsidiary of ORGANON & Co, Jersey City, NJ 07302, Manufactured by: SAMSUN BIOEPIS Co., Ltd, Incheon, Republic of Korea, NDC 78206-183-01.",
      "product_quantity": "5,518 packs (11,036 Syringes) 2 syringes/carton)",
      "reason_for_recall": "Lack of Assurance of Sterility.",
      "recall_initiation_date": "20251010",
      "center_classification_date": "20251024",
      "report_date": "20251105",
      "code_info": "Lot: F2505017, Expiry: 24-Jan-2027"
    }
  ]
}